Research Article
10 April 2013

Comparative Transcriptomic Analysis of the Burkholderia cepacia Tyrosine Kinase bceF Mutant Reveals a Role in Tolerance to Stress, Biofilm Formation, and Virulence

ABSTRACT

The bacterial tyrosine-kinase (BY-kinase) family comprises the major group of bacterial enzymes endowed with tyrosine kinase activity. We previously showed that the BceF protein from Burkholderia cepacia IST408 belongs to this BY-kinase family and is involved in the biosynthesis of the exopolysaccharide cepacian. However, little is known about the extent of regulation of this protein kinase activity. In order to examine this regulation, we performed a comparative transcriptome profile between the bceF mutant and wild-type B. cepacia IST408. The analyses led to identification of 630 genes whose expression was significantly changed. Genes with decreased expression in the bceF mutant were related to stress response, motility, cell adhesion, and carbon and energy metabolism. Genes with increased expression were related to intracellular signaling and lipid metabolism. Mutation of bceF led to reduced survival under heat shock and UV light exposure, reduced swimming motility, and alteration in biofilm architecture when grown in vitro. Consistent with some of these phenotypes, the bceF mutant demonstrated elevated levels of cyclic-di-GMP. Furthermore, BceF contributed to the virulence of B. cepacia for larvae of the Greater wax moth, Galleria mellonella. Taken together, BceF appears to play a considerable role in many cellular processes, including biofilm formation and virulence. As homologues of BceF occur in a number of pathogenic and plant-associated Burkholderia strains, the modulation of bacterial behavior through tyrosine kinase activity is most likely a widely occurring phenomenon.

INTRODUCTION

Bacterial tyrosine kinases (BY-kinases) are best characterized for regulating the biosynthesis and the export of bacterial extracellular carbohydrate polymers in both Gram-positive and Gram-negative bacteria. These proteins comprise two domains: a transmembrane activator domain with a large extracellular loop and an intracellular catalytic domain encompassing the ATP-binding site and tyrosine-rich region (1). These two domains can either be linked in a single polypeptide, such as in Proteobacteria and Actinobacteria, or split into two separate proteins encoded by adjacent genes, as in the Firmicutes (1). Resolution of the BY-kinase tridimensional structures showed no resemblance to their mammalian counterparts, and therefore these proteins are seen as good targets for antibacterial drug design (2).
A number of studies have shown the importance of BY-kinases in polysaccharide biosynthesis, mainly as components of a multienzymatic complex responsible for polysaccharide polymerization and export (3). Moreover, several enzymes involved in sugar-nucleotide biosynthesis and repeat unit formation have also been identified as phosphorylation targets of BY-kinases. For example, Escherichia coli Wzc and Bacillus subtilis PtkA BY-kinases were found to phosphorylate UDP-glucose dehydrogenase enzymes (4, 5), EpsD from Streptococcus thermophilus (6) and Wzc of Klebsiella pneumoniae (7) were found to phosphorylate the undecaprenyl-phosphate glycosyltransferases EpsE and WcaJ, respectively, and Cap5B2 from Staphylococcus aureus was found to phosphorylate the UDP-acetyl-mannosamine dehydrogenase Cap5O (8). In addition, BY-kinases have been demonstrated to have other cellular targets not related to polysaccharide biosynthesis, as is the case for the E. coli alternative heat shock sigma factor RpoH and the RpoE anti-sigma factor RseA (9), integrase proteins (Int) of coliphage HK022 (10), and single-stranded DNA-binding proteins SsbA and SsbB from Bacillus subtilis (11). Besides the genetic and biochemical analyses of individual targets of BY-kinases reported above, other bacterial tyrosine-phosphorylated proteins have been identified by gel-free proteomics approaches in organisms such as E. coli (12), B. subtilis (13, 14), Listeria monocytogenes (15), Streptococcus pneumoniae (16), and Pseudomonas species (17), to name a few. These tyrosine-phosphorylated proteins are involved in several cellular processes, such as stress responses, DNA metabolism, transcription, translation, central metabolism, cell division, and cell wall polysaccharide biosynthesis, among others (18, 19). A recent study demonstrated that tyrosine phosphorylation on target proteins not only modulates their enzymatic activity but also their correct cellular localization (20), adding a new dimension to the role of tyrosine phosphorylation in the bacterial cell.
Bacteria belonging to Burkholderia cepacia complex (Bcc) are important opportunistic pathogens, especially for cystic fibrosis (CF) and chronic granulomatous disease patients. These pathogens can cause deterioration of lung function, and some patients develop a condition known as cepacia syndrome, characterized by a fatal necrotizing pneumonia accompanied by septicemia (21). Bcc bacteria produce a variety of virulence factors, one of them being the exopolysaccharide (EPS) cepacian produced by most Bcc isolates (2224). This EPS is thought to be involved in persistence of the bacteria in CF lungs by their interactions with antimicrobial peptides, by interfering with the function of key components of the pulmonary host defense due to their capacity to scavenge reactive oxygen species, and by their involvement in biofilm formation (reviewed in reference 25). Another exopolysaccharide of Burkholderia was recently identified as relevant for biofilm matrix formation (26). The chemical structure of this new EPS has not yet been determined, but its biosynthetic genetic locus (gene cluster BCAM1330-BCAM1341 in Burkholderia cenocepacia J2315) encompasses several typical EPS-related genes encoding putative glycosyltransferases, polysaccharide-modifying enzymes, polysaccharide export proteins, and a BY-kinase protein (26). Among the genes involved in the biosynthesis of the exopolysaccharide cepacian is bceF, which encodes another BY-kinase (27). Disruption of the bceF gene compromised cepacian biosynthesis and the ability to produce thick biofilms in vitro (28). Furthermore, mortality was completely absent in gp91phox−/− mice challenged with a bceF transposon mutant, while in another mutant for the bceI gene, which encodes a putative polysaccharide polymerase, infected mice died 5 days later than those infected with the wild-type Burkholderia cepacia IST408 strain (29). The differences in virulence of the bceF and bceI EPS-deficient transposon mutants (29), together with the knowledge that BY-kinases have several endogenous targets in the cell, prompted us to evaluate which cellular processes require the BceF tyrosine kinase and may account for the observed differences in virulence. To accomplish this, transcriptome profiling of the wild-type B. cepacia IST408 and the EPS-deficient bceF::Tp and bceE::Tp isogenic insertion mutants was carried out. Based on the gene expression results, a series of phenotypic traits were compared to identify the pathways in which this BY-kinase may play a role.

MATERIALS AND METHODS

Bacterial strains, plasmids, and growth conditions.

The strains and plasmids used in this work are listed in Table 1. E. coli was grown in LB medium at 37°C. Unless otherwise stated, B. cepacia strains were grown in LB, pseudomonas isolation agar (PIA), or in EPS-producing S medium at 30°C (22). Growth media were supplemented with antibiotics when required to maintain the selective pressure at the following concentrations (in μg/ml): for B. cepacia, trimethoprim at 100, chloramphenicol at 300, and tetracycline at 400; for E. coli, trimethoprim at 100, chloramphenicol at 25, ampicillin at 100, tetracycline at 10, and kanamycin at 50.
Table 1
Table 1 Strains and plasmids used in this study
Strain or plasmidGenotype or descriptionaReference or source
Escherichia coli strains  
    XL1-BluerecA1 lac [F′ proAB lacIq ZαM15 Tn10 (Tcr)] thi51
    αDH5recA1 ΔlacU169 ϕ80 lacZΔM15BRL
Burkholderia cepacia strains  
    IST408Cystic fibrosis isolate, EPS+22
    IST408 bceE::TpIST408 derivative with bceE gene disrupted by Tpr gene cassetteThis work
    IST408 bceF::TpIST408 derivative with bceF gene disrupted by Tpr gene cassette28
Plasmids  
    pBCSKPhagemid derived from pUC19, CmrStratagene
    pRK2013Tra+ Mob+ (RK2) Km::Tn7 ColEl origin, helper plasmid, Kmr52
    pUC-TPpUC-GM derivative with 1.1-kb Tpr gene cassette, Apr Tpr53
    pDA17oripBBR1 PDHFR Tetr54
    pIN25oripBBR Δmob, GFP, Cmr55
    pLM56-1pBCSK derivative containing 2,411-bp KpnI/EcoRI fragment encompassing bceE and flanking regionsThis work
    pLM56-4pLM56-1 derivative containing Tpr gene cassette at XhoI site disrupting bceEThis work
    pLM127-4pDA17 derivative containing 1,329-bp NdeI/XbaI fragment with rpoH coding regionThis work
    pLM127-9pDA17 derivative containing 2,239-bp NdeI/XbaI fragment with bceF coding regionThis work
    pLM127-11pDA17 derivative containing 1,100-bp NdeI/XbaI fragment with bceE coding regionThis work
a
Abbreviations: Cmr, chloramphenicol resistance; Tpr, trimethoprim resistance; Apr, ampicillin resistance; Tetr, tetracycline resistance; Kmr, kanamycin resistance.

DNA manipulation techniques.

Total DNA was extracted from bacterial cells by using the DNeasy blood and tissue kit (Qiagen), following the manufacturer's instructions. Plasmid DNA isolation and purification, DNA restriction/modification, agarose gel electrophoresis, and E. coli transformation were carried out using standard procedures (30). B. cepacia electrocompetent cells, prepared as previously described (28), were transformed by electroporation using a Bio-Rad Gene Pulser II (200 Ω, 25 μF, 2.5 kV) and grown overnight before being plated in selective medium. Plasmids for complementation experiments and pIN25 expressing the green fluorescence protein (GFP) were mobilized into Burkholderia cepacia strains by triparental conjugation using plasmid pRK2013 as the helper.

Construction of the bceE insertion mutation.

To obtain a B. cepacia IST408 bceE disruption, a 2,411-bp KpnI/EcoRI fragment containing the bceE coding region and flanking regions was amplified using primers BceE-up (5′-CGAGGTACCCGTGATCGTCA; restriction sites are shown in italics) and BceE-low (5′-GATGAATTCGACGTCGGCCACTT) and cloned into the same restriction sites of pBCSK. The plasmid obtained (pLM56-1) was further digested with XhoI, which has a single recognition site within the bceE coding region. The trimethoprim (Tp) resistance cassette was obtained from pUC-TP and was cloned into pLM56-1, resulting in the plasmid pLM56-4, which transcribed the cassette in the same orientation as the bceE gene. This plasmid was introduced into B. cepacia IST408 by electroporation, and transformants were selected by growth on PIA medium with trimethoprim. The colonies obtained were then screened in the presence of chloramphenicol. Colonies that did not grow in the presence of chloramphenicol but were trimethoprim resistant were considered candidates for allelic exchange of bceE by the bceE::Tp construct. The candidate insertion mutant was further characterized by PCR amplification and DNA sequencing.

Construction of plasmids for complementation experiments.

PCR was used to amplify the coding region of bceE (primers bceE-fw, 5′-GAACATATGCTGAAACGCCCGATG, and bceE-rev, 5′-TGATCTAGAGGAGCAGCTGGCCGAGGA; restriction sites are in italics); bceF (primers bceF-fw, 5′-GAACATATGGTGAACACGCAAGCGAAA, and bceF-rev, 5′-TTATCTAGAATGCGGATCAGGCGCTCA), and rpoH (BCAL0787 in B. cenocepacia J2315; primers rpoH-fw, 5′-TTTCATATGAGCAACGCCCTGACCCTC, and rpoH-rev, 5′-CCGTCTAGAAACCGGTGGAAAAAATTG). Following restriction with NdeI and XbaI, each gene was cloned in the same restriction sites of pDA17. The plasmids obtained were pLM127-4, pLM127-9, and pLM127-11, carrying the rpoH, bceF, and bceE genes, respectively (Table 1). The nucleotide sequences of the cloned genes were confirmed by DNA sequencing.

Isolation and processing of RNA and DNA samples.

For expression profiling, overnight cultures of wild-type B. cepacia IST408 and the isogenic mutants bceE::Tp and bceF::Tp were grown in LB medium and diluted into S medium to an initial optical density at 640 nm (OD640) of 0.1. Triplicate 250-ml Erlenmeyer flasks containing 100 ml of medium were inoculated with each strain and cultured at 30°C with agitation at 250 rpm for 12 h. These bacterial cells were resuspended in RNAprotect bacteria reagent (Qiagen), and total RNA extraction was carried out using the RNeasy minikit (Qiagen), followed by DNase treatment (RNase-free DNase set; Qiagen) according to the manufacturer's recommendations. RNA integrity was checked on an Agilent 2100 Bioanalyser using an RNA Nano assay. RNA was processed for use on Affymetrix custom dual-species Burkholderia arrays (31), according to the manufacturer's prokaryotic target preparation assay instructions. Briefly, 10 μg of total RNA containing spiked poly(A) RNA controls [GeneChip poly(A) RNA control kit; Affymetrix, Santa Clara, CA] was used in a reverse transcription reaction with random primers (Invitrogen Life Technologies) to generate first-strand cDNA. After removal of RNA, 2 μg of cDNA was fragmented with DNase and end labeled with biotin by using terminal polynucleotidyl transferase (GeneChip WT terminal labeling kit; Affymetrix). The size distribution of the fragmented and end-labeled cDNA was assessed using the Agilent 2100 Bioanalyzer. Two micrograms of end-labeled fragmented cDNA was used in a 200-μl hybridization cocktail containing hybridization controls, and the mixture was hybridized on arrays for 16 h at 50°C. Modified posthybridization wash and double-stain protocols (FLEX450_0005; GeneChip HWS kit; Affymetrix) were used on a GeneChip fluidics station 450. Arrays were scanned on an Affymetrix GeneChip scanner 3000 7G. Biological triplicates of RNA from each bacterial culture were processed and analyzed.
For DNA analysis, a total of 1.5 μg of genomic DNA from B. cepacia IST408 was labeled using the Bioprime DNA labeling system (Invitrogen, Paisley, United Kingdom) following a strategy for genomic DNA hybridization to GeneChips developed by Hammond and coauthors (32). Cleanup was performed using the MinElute PCR purification kit (Qiagen, Hilden, Germany), and quality was checked on an Agilent 2100 Bioanalyser using a DNA 1000 assay. Five micrograms of labeled DNA was analyzed on an Affymetrix custom dual-species Burkholderia array following the protocol described above for RNA samples.

Microarray analysis.

For microarray analysis, DNA-based probe selection was performed using Xspecies DNA hyb CDF batchmaker v3.2 (32; http://affymetrix.arabidopsis.info/xspecies/). An optimal signal cutoff of 80 and minimum number of probes per probe set of 7 were determined empirically, resulting in the masking of 24,223 of the original 226,576 probes on the array and the exclusion of 156 probe sets. The new cdf file created (Bcc1sa520656F_Xspecies.CEL80.cdf) was used in a DNA Chip Analyzer 2008 for the subsequent gene expression analyses. The 9 expression arrays were normalized to a baseline array with median CEL intensity by applying an invariant set normalization method (33). Normalized CEL intensities of the arrays were used to obtain model-based gene expression indices based on a perfect match (PM)-only model (34). Replicate data (triplicates) for each bacterial isolate were weighted gene-wise by using the inverse squared standard errors as weights. All genes compared were considered differentially expressed if the 90% lower confidence bound of the fold change (LCB) between the experimental value and baseline was above 1.2. The lower confidence bound criterion meant that we could be 90% confident that the fold change was a value between the lower confidence bound and a variable upper confidence bound. Li and Wong have shown that the lower confidence bound is a conservative estimate of the fold change and therefore more reliable as a ranking statistic for changes in gene expression (33).
This comparison resulted in 630 differentially expressed transcripts with a median false-discovery rate (FDR) of 1.7% when the bceF::Tp mutant was compared with the wild-type IST408. The comparison of the bceE::Tp mutant transcriptome with the one of IST408 showed 5 genes differentially expressed (≥1.6-fold change lower confidence bound, with a resulting FDR of 0%).

qRT-PCR assays.

DNA microarray data were validated by real-time quantitative reverse transcription-PCR (qRT-PCR) as previously described (24). Total RNA was used in a reverse transcription reaction with TaqMan reverse transcription reagents (Applied Biosystems). qRT-PCR amplification of each gene (for primer sequences, see Table S1 in the supplemental material) was performed with a model 7500 thermocycler (Applied Biosystems). The expression ratio of the target genes was determined relative to the reference gene lepA, which showed no variation in transcript abundance under the conditions tested. Relative quantification of gene expression by real-time qRT-PCR was determined using the ΔΔCT method (35).

In vivo complementation of EPS-deficient strains.

Plasmids pDA17, pLM127-9 (+pbceF), and pLM127-11 (+pbceE) were mobilized into the parental strains IST408, IST408 bceF::Tp, and IST408 bceE::Tp, respectively, by triparental conjugation. To determine their ability to restore cepacian biosynthesis in vivo these strains were grown in liquid S medium over 3 days at 30°C. EPS quantification was based on the dry weight of EPS recovered after ethanol precipitation of culture supernatants, as described before (28).

Stress conditions.

Survival of Burkholderia strains to heat stress was tested by inoculation of overnight cultures into 4 ml of S medium to a final OD640 of 0.1. Strains were allowed to grow until the OD640 reached 0.6 before being submitted to a static incubation at 50°C in a water bath for 20 min. At 4- or 8-min intervals, an aliquot of 100 μl was serially diluted and plated onto LB agar. After 48 h of incubation at 30°C, CFU were counted. To test tolerance to UV irradiation, 500-μl aliquots of the bacterial cell suspensions prepared in S medium (OD640, 0.1) were transferred into PMMA cuvettes (VWR) and immediately exposed to UV irradiation (λ, 254 nm) for different times. Aliquots from each cell suspension were serially diluted and plated onto LB agar, and plates were incubated for 2 days at 30°C before CFU counting. Each experiment was repeated at least three times.

Detection of cyclic-di-GMP.

The method for detection of cyclic-di-GMP from B. cepacia IST404 and its derivative mutants bceF::Tp and bceE::Tp was adapted from that reported by Ryan and colleagues (36). Briefly, cells (300 μg) were harvested from agar plates or shaking cultures grown at 30°C in S medium for 12, 24, and 48 h. Nucleotides were extracted by resuspending the cells in water and heating at 100°C for 5 min. The extract was lyophilized, resuspended in 500 μl of water certified for high-performance liquid chromatography (HPLC) analysis, and filtered (0.2-μm pore size). Extracts equivalent to 150 μg (wt/wt) of cells were adjusted to 500 μl in 0.1 M triethylammonium acetate (TEAA) buffer (pH 4.5) and subjected to HPLC separation. HPLC was performed on a 250- by 4.6-mm reverse-phase column (Hypersil ODS 5 μm; Hypersil-Keystone) at room temperature, with detection at 260 and 280 nm, on an ICS-U3000 IC system (Dionex, United Kingdom). Running conditions were optimized by using synthetic cyclic-di-GMP (Biolog). Runs were carried out in 0.15 M TEAA buffer (pH 4.5) at 1 ml/min, using a multistep gradient of acetonitrile. Relevant fractions of 1 ml were collected, lyophilized, and resuspended in 10 μl H2O. For quantification, a standard curve was established whereby synthetic cyclic-di-GMP was added to relevant cell extracts. The area of the peak was used to estimate the amount of cyclic-di-GMP in a sample in reference to the wet cell weight. Quantification was further validated by mass spectrometry using matrix-assisted laser desorption ionization–time of flight analysis.

Motility tests.

For the motility test, swimming plates with 0.3% (wt/vol) Bacto agar (Difco) and swarming plates with 0.5% (wt/vol) Noble agar were prepared using S medium and LB with 0.5% (wt/vol) glucose, respectively. For estimation of motility, overnight bacterial cultures (5 μl) were inoculated onto an agar surface and incubated at 30°C for 48 h, followed by colony diameter determinations.

Pellicle assay.

For the pellicle assay, overnight cultures were inoculated in tubes containing 5 ml of S medium at an OD640 of 1.0 and kept static for 3 days at 30°C. Pellicles were assayed by visual inspection of the air-liquid interface, and the complete coverage of the surface with a cell layer was considered the extent of pellicle formation.

Cultivation of biofilms.

Biofilm formation assays in microtiter plates were performed as previously described (28, 37). Biofilm formation was also studied under continuous flow conditions using the sterile Stovall 3-chamber flow cell system (Fisher Scientific). Briefly, S medium was pumped into the system for 3 h prior to inoculation of bacteria to wash and prevent system bubbles, using an Ismatec peristaltic pump. The flow chambers were inoculated by injecting in each flow channel 300-μl aliquots of the overnight cultures of B. cepacia IST408, bceF::Tp mutant, or bceE::Tp mutant harboring pIN25 expressing the gfp gene to a dilution resulting in an OD640 of 0.2. After inoculation, the flow channels were left without flow for 3 h, after which S medium flow was restarted at a rate of 0.4 ml/min. The flow cell system was kept at 30°C during the experiments, except during confocal microscopy analysis.

Microscopy and image analysis.

Biofilm formation was examined at 48 h by scanning confocal laser microscopy on a Leica TCS SP5 inverted confocal microscope (DMI6000; Leica Microsystems CMS GmbH, Mannheim, Germany) with an argon laser for excitation. A 63× apochromatic objective with a numerical aperture of 1.2 (Zeiss, Jena, Germany) was used for all experiments. Strains under study expressed GFP, which allowed fluorescent visualization of bacterial cells. Data acquired were analyzed using the ImageJ program (http://rsbweb.nih.gov/ij/). Biomass thickness and the roughness coefficient were calculated using COMSTAT2 (http://www.comstat.dk) (38; M. Vorregaard, B. K. Ersbøll, L. Yang, J. A. J. Haagensen, S. Molin, and C. Sternberg, personal communication). The results shown were obtained using the three-dimensional (3D) viewer function and are representative of 3 independent experiments.

Galleria mellonella killing assays.

B. cepacia strains were screened for virulence in a G. mellonella wax moth larvae infection model as previously described (39). Larvae were injected with approximately 2 × 106 bacterial cells suspended in 10 mM MgSO4 with 1.2 mg/ml ampicillin and incubated in the dark at 30°C. Control larvae were injected with 10 mM MgSO4 with 1.2 mg/ml ampicillin. Larvae were scored as dead or alive for a period of 2 days. Duplicates of 10 larvae were used in each experiment, and three independent assays with different larvae generations were performed.

Microarray data accession number.

Microarray data were deposited in the Gene Expression Omnibus (GEO) repository at NCBI under accession number GSE38183 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE38183).

RESULTS

Gene expression profiles of mutants bceE::Tp and bceF::Tp versus wild-type B. cepacia IST408.

Since the bceF::Tp mutant is unable to produce exopolysaccharide while the wild-type strain B. cepacia IST408 is (28), it was necessary to exclude that the possible differences for the strains were caused by the EPS directly and not by the presence/absence of the BceF kinase. Therefore, we constructed an insertion mutant for the bceE gene (located upstream of bceF) that encoded the predicted auxiliary membrane protein BceE, which is required for cepacian export. This insertion mutant, B. cepacia IST408 bceE::Tp, showed the same growth behavior as the wild-type B. cepacia IST408 strain and the bceF::Tp mutant (data not shown) and, as expected, was unable to produce cepacian (Fig. 1). In trans complementation of bceE::Tp and bceF::Tp mutants with the constitutive pDA17 vector harboring bceE (+pbceE) or bceF (+pbceF), respectively, restored EPS production to the wild-type level (Fig. 1).
Fig 1
Fig 1 Exopolysaccharide production in liquid S medium at 30°C by Burkholderia cepacia IST408/pDA17 (◆), IST408 bceE::Tp/pDA17 (○), IST408 bceE::Tp/+pbceE (●), IST408 bceF::Tp/pDA17 (□), and IST408 bceF::Tp/+pbceF (■). The data are means ± standard deviations from the results of at least three independent experiments.
To gain insight into the broader role of BceF tyrosine kinase, a transcriptomic approach using a custom Burkholderia GeneChip array was followed. Since we used B. cepacia IST408 as a model organism and the species represented on the array are B. cenocepacia J2315 and B. multivorans ATCC 17616 (31), there was the need to determine which individual probes representing a transcript hybridized efficiently to B. cepacia IST408 genomic DNA. Therefore, the genomic DNA of this bacterium was hybridized to the microarray. Setting a threshold for minimum intensity of 80 and for at least 7 probes per probe set within the software Xspecies (32), we retained 14,752 probe sets. Under these conditions, the comparison of the gene expression profile of the bceE::Tp mutant with that of IST408 showed 1 gene with statistically significant increased expression and 4 genes with statistically significant decreased expression (≥1.6-fold change lower confidence bound with a resulting false-discovery rate of 0%). The gene with increased expression encodes a putative metallo-beta-lactamase, and the genes with decreased expression are predicted to be involved in acetoin metabolism (see Table S2 in the supplemental material). These results confirmed that after 12 h of growth in S medium, the transcriptome of B. cepacia IST408 and of the bceE::Tp mutant derivative are very similar, and any differences between the bceF::Tp and IST408 transcriptomes are due to the presence/absence of the BceF kinase. The comparison of the bceF::Tp mutant transcriptome with that of the wild-type B. cepacia IST408 strain (≥1.2-fold change lower confidence bound with a resulting false-discovery rate of ≤1.7%) showed 304 genes with statistically significant increased expression and 326 genes with statistically significant decreased expression. Almost half (43%) of the identified genes belonged to the category of poorly characterized genes or had no COG classification. Figure 2 shows the major categories of the remaining differentially expressed genes. Globally, our results indicated that in the absence of BceF tyrosine kinase, the cell's transcriptome showed a significant decrease in the expression of genes related to cell motility, stress response (universal stress proteins, heat shock proteins, proteases, etc.), and DNA replication, recombination, and repair (Table 2). In contrast the expression levels of genes encoding transcriptional regulators or lipid metabolism and genes related to cyclic-di-GMP signaling were increased in the bceF::Tp mutant transcriptome (Table 2). (The complete lists of differentially expressed genes are presented in Tables S3 and S4 in the supplemental material.)
Fig 2
Fig 2 Number of genes with differential expression according to the major clusters of orthologous groups (COGs) categories when the bceF::Tp mutant was compared to wild-type B. cepacia IST408. A total of 630 genes with statistically significant altered expression were obtained by using a custom Affymetrix Burkholderia GeneChip. (C) Energy production and conversion; (D) cell division; (E) amino acid transport and metabolism; (F) nucleotide transport and metabolism; (G) carbohydrate transport and metabolism; (H) coenzyme transport and metabolism; (I) lipid transport and metabolism; (J) translation, ribosomal structure, and biogenesis; (K) transcription; (L) replication, recombination, and repair; (M) cell wall, membrane, and envelope biogenesis; (N) cell motility; (O) posttranslational modification and protein turnover; (P) inorganic ion transport and metabolism; (Q) secondary metabolite biosynthesis and transport; (T) signal transduction; (U) intracellular trafficking.
Table 2
Table 2 Differentially expressed genes for the B. cepacia IST408 bceF::Tp mutant transcriptome versus IST408, separated by functional group
Functional classGene identifierLB-FCaFCbGene nameDescription
Cell motilityBCAL0113−1.3−1.5fliD1B-type flagellar hook-associated protein 2 (HAP2)
 BCAL0131−1.2−1.5tarMethyl-accepting chemotaxis protein
 BCAL0136−1.2−1.5cheZChemotaxis regulator CheZ
 BCAL0563−1.3−1.6flgAFlagellar basal body P-ring biosynthesis protein FlgA
 BCAL0564−1.2−1.5flgBFlagellar basal body rod protein FlgB
 BCAL0565−1.3−1.6flgCFlagellar basal body rod protein FlgC
 BCAL0567−1.2−1.7flgE1Flagellar basal body FlgE domain protein
 BCAL15311.31.6 Flp-type pilus assembly protein
 BCAL15331.31.9 Putative lipoprotein
 BCAL1677−1.4−1.8 Putative type 1 fimbrial protein
Envelope biogenesisBCAL0287−2.0−3.1 OmpW family protein
 BCAL31221.31.7wbiFO-antigen glycosyltransferase
 BCAL31301.32.4wztABC transporter ATP-binding protein
 BCAL31311.41.7wzmABC transporter, membrane permease
 BCAM1204−1.5−2.0dadXAlanine racemase
Replication, recombination, and repairBCAL12041.51.9 Putative helicase
BCAL1897−1.4−1.7recRRecombination protein RecR
 BCAL1963−1.6−2.1 DNA polymerase III, delta prime subunit
 BCAL2188−1.3−1.7 Putative single-stranded DNA-specific exonuclease
 BCAL3005−1.3−1.6 Possible DNA polymerase/helicase
 BCAL3141−1.3−1.6 Holliday junction resolvase-like protein
 BCAL3256−1.2−1.5mutLDNA mismatch repair protein MutL
 BCAM1258−1.4−1.6 Putative DNA-binding protein
TranscriptionBCAL0562−1.2−1.6flgMNegative regulator of flagellin synthesis (anti-σ28)
 BCAL0787−1.3−1.8rpoHRNA polymerase factor σ32
 BCAL1879−1.3−1.7hfqRNA-binding Hfq protein
 BCAL1538−1.3−1.8hfq2RNA-binding Hfq protein
 BCAL3055−1.3−1.6nusBTranscription antitermination protein NusB
 BCAL31511.51.7 Putative transmembrane anti-σ factor
 BCAL3178−1.4−1.7 LysR family regulatory protein
 BCAM07421.61.9 LysR family regulatory protein
Regulatory/signal transductionBCAL0128−1.2−1.5cheYChemotaxis two-component response regulator CheY
 BCAL04301.31.7 Putative diguanylate cyclase
 BCAL1069−1.2−1.5cdpAPutative cyclic-di-GMP phosphodiesterase
 BCAL2011−1.3−1.6ompROsmolarity response regulator
 BCAM1162−1.3−1.5cheB3Chemotaxis-specific methylesterase
 BCAM16701.32.0 Putative cyclic-di-GMP signaling protein
Defense mechanismsBCAL0389−1.3−1.7dsbCThiol-disulfide interchange protein DsbC
 BCAL0807−1.5−2.2 ATP-dependent protease
 BCAL2119−1.5−2.2 Universal stress protein family protein
 BCAL2410−1.2−1.5 Rhodanese domain protein
 BCAL3006−1.4−1.8cspACold shock-like protein
 BCAL3147−1.3−1.8groES1Cochaperonin GroES
 BCAM0050−1.3−1.6 Universal stress protein family protein
 BCAM0278−1.3−1.9 Putative heat shock protein 21
 BCAM0294−1.3−1.8 Putative universal stress protein
 BCAM03091.61.9ftsHATP-dependent metalloprotease FtsH
 BCAM0703−1.3−1.4 Putative glutathione S-transferase domain
 BCAM2378−1.6−2.0pepXX-prolyl-dipeptidyl aminotransferase
TransportersBCAL0340−1.2−1.6 Putative lipoprotein (type VI)
 BCAL03411.21.6 Type VI secretion protein, VC_A0107 family
 BCAL03431.41.7hcpType VI secretion system effector, Hcp1 family
 BCAL03481.31.5bcsEType VI secretion-associated protein, ImpA family
 BCAL0350−1.3−1.9 Hypothetical protein BCAL0350 (type VI secretion)
 BCAL0742−1.2−1.5secBPreprotein translocase subunit SecB
 BCAL16461.42.0 Putative oligosaccharide ABC transporter protein
 BCAL30991.31.6 Putative branched-chain amino acid transport, permease
 BCAM07601.51.7hisQHistidine transport system permease
 BCAM07691.31.5 Ribose transport system permease protein
Energy conversionBCAL33421.31.6 Phosphoglycerate mutase
 BCAL3388−1.3−1.6gapAGlyceraldehyde 3-phosphate dehydrogenase 1
 BCAM0311−1.2−1.6 Putative 6-phosphofructokinase
 BCAM1581−1.4−1.9pckGPhosphoenolpyruvate carboxykinase (GTP)
Amino acid metabolismBCAL0073−1.4−1.7gcvPGlycine dehydrogenase
 BCAL0075−1.5−1.9gcvTGlycine cleavage system aminomethyltransferase T
 BCAL0632−1.5−2.0 Putative dehydrogenase
 BCAM0011−1.5−1.7tdhl-Threonine 3-dehydrogenase
Lipid metabolismBCAL08451.21.7acpPAcyl carrier protein
 BCAL0992−1.2−1.6fabH23-Oxoacyl-(acyl carrier protein) synthase III
 BCAL21051.21.5clsCardiolipin synthetase
 BCAL23221.31.5 Enoyl coenzyme A hydratase
 BCAL3191−1.2−1.7 Putative glutaryl coenzyme A dehydrogenase
 BCAM0142−1.2−1.4 Putative acyl coenzyme A dehydrogenase family protein
 BCAM12141.41.8 Putative dioxygenase
 BCAM20011.31.4 Short-chain dehydrogenase reductase
 BCAM22831.21.6 Short-chain dehydrogenase
 BCAM2568−1.4−1.7 Beta-ketoadipyl–coenzyme A thiolase
Coenzyme and inorganic ion transport and metabolismBCAL0040−1.4−1.7hemEUroporphyrinogen decarboxylase
BCAL0475−1.2−1.6 Putative 6-pyruvoyl tetrahydropterin synthase
 BCAL0665−1.5−1.7bioDDithiobiotin synthetase
 BCAL1043−1.3−1.6gudDGlucarate dehydratase
 BCAL1047−1.2−1.5pdxYPyridoxamine kinase
 BCAL1728−1.3−1.6cbiDCobalt precorrin 6A synthase
 BCAL2112−1.2−1.5thiDPhosphomethylpyrimidine kinase
 BCAL24581.62.0rubARubredoxin-type Fe(Cys)4 protein
 BCAL2782−1. 3−1.7pdxHPyridoxamine 5′-phosphate oxidase
 BCAL3049−1.2−1.6hemLGlutamate-1-semialdehyde 2,1-aminomutase
 BCAL3094−1.5−2.2hemNCoproporphyrinogen III oxidase
 BCAM26261.31.6huvAPutative heme receptor protein
Nucleotide metabolismBCAL0012−1.5−1.9 Adenylate cyclase
 BCAL0635−1.3−1.5yagTPutative xanthine dehydrogenase iron-sulfur binding subunit
 BCAL3140−1.2−1.5pyrRBifunctional pyrimidine regulatory protein PyrR uracil phosphoribosyltransferase
 BCAL3172−1.4−1.8xdhBXanthine dehydrogenase, molybdopterin-binding subunit
 BCAL3400−1.2−1.6pyrFOrotidine 5′-phosphate decarboxylase
a
LB-FC, lower bound of fold change.
b
FC, fold change.
To confirm the data obtained by microarray analysis, expression levels of 11 representative genes from COGs C, E, K, N, R, T, and U were analyzed by qRT-PCR. The results obtained were in good agreement with the microarray data (Table 3).
Table 3
Table 3 Quantitative real-time RT-PCR analysis results for the B. cepacia IST408 wild-type strain and bceE::Tp and bceF::Tp isogenic mutant derivatives
Comparison and gene identifier (gene name)Microarray LB-FC (FC)aReal-time fold change ± SD
bceF::Tp vs IST408  
    BCAL0073 (gcvP)−1.4 (−1.7)−1.5 ± 0.4
    BCAL0564 (flgB)−1.2 (−1.5)−1.7 ± 1.2
    BCAL0787 (rpoH)−1.3 (−1.8)−1.9 ± 0.1
    BCAL1677−1.4 (−1.8)−4.0 ± 0.2
    BCAL2011 (ompR)−1.3 (−1.6)−1.9 ± 0.2
    BCAL15311.3 (1.6)1.2 ± 0.3
    BCAL34861.2 (1.4)3.1 ± 0.1
    BCAM2054 (bcscD)1.4 (1.8)2.3 ± 0.1
    BCAM23481.5 (1.6)2.1 ± 0.1
bceE::Tp vs IST408  
    BCAL1910 (acoB)−1.8 (−2.6)−1.9 ± 0.4
    BCAM2378 (pepX)−1.7 (−2.3)−1.8 ± 0.1
a
LB-FC, lower bound of fold change; FC, fold change.

Genes involved in metabolism.

Metabolic changes accounted for one-third of differentially expressed genes between the bceF::Tp mutant and the wild-type strain. In particular, genes involved in energy conversion, coenzyme metabolism, and amino acid metabolism had decreased expression in the bceF::Tp mutant, while genes related to lipid metabolism and nutrient uptake had increased expression. Among the genes with decreased expression in the bceF::Tp mutant, there were genes encoding glycolytic enzymes (gapA and BCAM0311) and the gene pckG, which encodes the phosphoenolpyruvate carboxykinase enzyme that removes oxaloactetate from the citrate cycle into the gluconeogenesis pathway (Table 2). The genes with decreased expression required for coenzyme metabolism are involved in the metabolism of porphyrin, thiamine, folate, ascorbate, and biotin. In the category of amino acid metabolism, we observed a 1.7- to 1.9-fold decrease in expression of the genes gcvP and gcvT, which encode two of the enzymes of the glycine cleavage system that is involved in the synthesis of one-carbon (C1) units used in the biosynthesis of purines, methionine, and thymine and for other cellular methylation reactions.
A category of genes with increased expression in the bceF mutant encodes ABC transporters involved in monosaccharide, amino acid, peptide, and mineral and organic ion transport (Table 2). With regard to lipid metabolism, we observed a 1.5-fold increase in expression of the cls gene, which encodes cardiolipin synthetase. Cardiolipin is an anionic tetraacylphospholip found in the cytoplasmic membrane of bacteria, and it is important for optimal assembly of protein complexes, such as the electron transport complexes (40). We also observed increased expression of genes involved in fatty acid biosynthesis (BCAM2001 and BCAM2283) and decreased expression of genes for their catabolism (BCAL3191 and BCAM0142). It is thus possible that in the absence of BceF kinase, bacteria need to restructure the membrane lipid composition, perhaps to stabilize some protein complexes and/or alter permeability.

Genes involved in envelope biogenesis.

Regarding cell wall biosynthesis, the gene dadX, which encodes a protein that catalyzes the reversible racemization of l-Ala and d-Ala, showed 2.0-fold decreased expression in the bceF::Tp mutant. As d-Ala is an essential component of the cell wall peptidoglycan, we cannot exclude that the bceF::Tp mutant may have differences in its peptidoglycan structure. Another important component of the cell wall is the lipopolysaccharide. Three genes involved in O-antigen biosynthesis and one in lipid A modification showed 1.7- to 2.4-fold increased expression in the bceF::Tp mutant strain. One of the genes, wbiF, encodes a glycosyltransferase involved in the transfer of a sugar residue to the O-antigen core oligosaccharide. The other two genes were wzm and wzt, which encode a predicted two-component ABC transporter required for O-antigen export across the plasma membrane. The last gene, with a 1.8-fold increase in expression, was BCAM1214, which encodes a protein homologue of LpxO dioxygenase enzymes from other bacteria; these enzymes are required for hydroxylation of lipid A. It is thus possible that the bceF::Tp mutant strain produces a different amount of and/or a modified lipopolysaccharide.
Microarray data also showed 1.6-fold decreased expression of ompR, which encodes the response regulator OmpR, in the bceF::Tp mutant. Together with the histidine kinase EnvZ, OmpR is involved in regulating outer membrane composition in several bacteria, is required for curli expression and for biofilm formation in E. coli, and is also involved in resistance to phagocytosis and in survival within macrophages by Yersinia pestis (41, 42). Although the genes regulated by EnvZ/OmpR in Burkholderia are unknown, we observed decreased expression of at least 9 genes encoding putative lipoproteins and outer membrane proteins in the bceF::Tp mutant, while only 4 showed increased expression. In addition, the secB gene, which encodes the preprotein translocase of the Sec pathway necessary for the export of proteins to the periplasm, outer membrane, or extracellular milieu, also showed reduced expression in the bceF::Tp mutant. Taken together, these observations suggest that in addition to the absence of exopolysaccharide, the bceF::Tp mutant must have other differences in its cell wall that affect permeability or interactions with the surrounding environment.

Mutation of the bceF gene suggests a role for it in the response to stress.

In our data set, the gene rpoH encoding the sigma 32 alternative sigma factor showed 1.8-fold decreased expression in the bceF::Tp mutant compared with the IST408 wild-type strain. RpoH mediates the heat shock response, but it is also activated under conditions that destabilize folded proteins or make correct nascent protein folding more difficult (43). The comparison of our data with genes that are known to be regulated by RpoH in E. coli (43) revealed many with decreased expression in the bceF::Tp mutant (Table 2). These genes encode chaperones GroES1 and HSP21, the dsbC genem which encodes a protein involved in disulfide bond formation, several genes that encode universal stress-related proteins, and genes encoding putative proteases. The RpoH regulon also encodes proteins involved in cofactor biosynthesis and iron-sulfur assembly (43) and, as we described above, several genes involved in cofactor biosynthesis showed decreased expression. Another function of the RpoH regulon is the protection of DNA and RNA. Hence, we observed a decreased expression of genes involved in the repair of DNA lesions (recR and mutL) in the bceF::Tp mutant, as well as a predicted Holliday junction resolvase-like protein (BCAL3141), a specific single-stranded DNA-specific exonuclease (BCAL2188), and the cold shock protein gene cspA. Also, gene nusB, whose product binds to RNA polymerase to alleviate the effects of supercoiling on transcription, and the RNA chaperone-encoding genes hfq and hfq2 showed decreased expression in the bceF::Tp mutant. To determine whether the decreased expression of the putative RpoH and its regulon members is relevant under heat shock conditions, wild-type IST408 and the bceE::Tp and bceF::Tp mutants and the complemented mutants were incubated at 50°C for 20 min, and CFU were counted at several time points (Fig. 3A). The results obtained showed a more sensitive phenotype for the bceF::Tp mutant, with the cells having a lower survival rate under heat stress. In trans complementation of the bceF::Tp mutant with the pDA17 vector containing the bceF or rpoH genes rescued its heat-sensitive phenotype (Fig. 3A). When cells were exposed to UV light for a period of time, we also observed a decrease in the survival rate of the bceF::Tp mutant compared to the bceE::Tp and wild-type B. cepacia, which was rescued by the introduction of bceF or rpoH genes carried by pDA17 (Fig. 3B).
Fig 3
Fig 3 Bacterial survival under heat and UV light stresses. Cells of B. cepacia IST408/pDA17 (◆), IST408 bceE::Tp/pDA17 (○), IST408 bceF::Tp/pDA17 (□), IST408 bceF::Tp/+pbceF (■), and IST408 bceF::Tp/+prpoH () were incubated at 50°C (A) or under UV light exposure (B), and CFU determinations were made by plating the cells in LB medium at 30°C. The data are means ± standard deviations from the results of at least three independent experiments.
Although the RpoH regulon is also induced by oxidative stress, the only two genes with a putative role in antagonizing this type of stress and that showed decreased expression in the bceF::Tp mutant were BCAM0703, which encodes a putative glutathione S-transferase, and BCAL2410, which encodes a protein with a rhodanese domain (Table 2). Despite that, no differences were found between the wild-type strain and the mutants with respect to growth inhibition in the presence of oxidative stress agents, such as H2O2 or cumene hydroperoxide (data not shown).

Mutation of bceF affects motility and biofilm formation.

Analysis of gene expression levels in the flagellar regulon indicated 1.5-fold decreased expression in the bceF::Tp mutant of the cheY, cheB3, cheZ, and tar genes, whose products are involved in chemotaxis. In addition, the filament cap-encoding gene fliD1, the flagellar basal body-encoding genes flgABCE1, and flgM, which encodes the negative regulator of flagellin synthesis also displayed decreased expression in the bceF::Tp mutant (Table 2). To test whether differences in the expression of these genes led to a phenotype in semisolid medium, the swimming and swarming abilities of the strains were performed. Consistent with the gene expression data, we observed that after 24 h of incubation the bceF::Tp mutant displayed lower swimming and swarming motilities than the wild-type strain and the bceE::Tp mutant, but these phenotypes were complemented by the expression of the bceF gene from pDA17 (Fig. 4).
Fig 4
Fig 4 Swimming and swarming motilities of wild-type B. cepacia IST408, bceE and bceF mutants, and complemented mutants. Plates containing 0.3% and 0.6% purified agar were used to test swimming and swarming motilities, respectively. Plates were spotted with 5-μl of mid-exponential-phase B. cepacia cultures previously grown in S medium for 12 h at 30°C, and the size of each halo was measured. The data are means ± standard deviations from the results of at least three independent experiments.
We also compared cell-to-cell adhesion in wild-type bacteria and in the bceE::Tp and bceF::Tp mutants by using static broth cultures. The results showed that broth cultures of the wild-type strain remained visibly clear after 3 days of incubation, with clumping of the bacterial cells at the bottom of the culture tube (Fig. 5A). For this property, the bceE::Tp mutant showed an intermediate phenotype, and the broth culture of the bceF::Tp mutant showed mainly bacterial cells in suspension (Fig. 5A). Pellicle formation at the air-liquid interface was mainly observed in the wild-type IST408 and, to a lesser extent, in both mutants (Fig. 5A). Since pellicle formation is indicative of the production of an adhesive matrix, we first investigated biofilm formation under static conditions by measuring cell adhesion to an abiotic surface based on crystal violet staining. The bceF::Tp mutant biofilm at 48 h retained 2.0- and 1.3-fold less crystal violet than the biofilm of wild-type B. cepacia IST408 and the bceE::Tp mutant, respectively (Fig. 5B). Both mutant phenotypes were restored by expressing in trans from pDA17 the mutant strain defective gene. We also tested biofilm formation in continuous flow cells by constitutively expressing GFP from a plasmid in the three strains. After a 48-hour period, B. cepacia IST408 biofilms showed well-differentiated microcolonies with shapes resembling early cauliflower-like structures (Fig. 5C). The bceE::Tp mutant formed cell aggregates that covered more than 50% of the optical field, but without forming 3D macrocolonies as thick as the ones observed for the wild-type strain, with maximum thicknesses of 7.76 and 4.12 μm for the wild-type and bceE::Tp mutant, respectively. In contrast, the bceF::Tp mutant seemed to be unable to form mature biofilm forms, presenting small and scarce colonies throughout the chamber surface with a maximum thickness for this biofilm of 2.74 μm (Fig. 5C). The biomass contained in each strain's biofilm was also evaluated using COMSTAT2, with the parental IST408 biofilms having a biomass volume-to-surface ratio of 6.61 μm3/μm2, the bceE::Tp mutant with 3.45 μm3/μm2, and the bceF::Tp mutant with 2.53 μm3/μm2, which is consistent with the biofilm formation data obtained using crystal violet staining.
Fig 5
Fig 5 Effects of bceE and bceF mutations on biofilm formation. (A) Pellicle formation in a static S medium liquid culture of B. cepacia IST408 and isogenic mutants bceE::Tp and bceF::Tp. (B) Biofilm formation measured by crystal violet staining in an assay using static broth cultures of B. cepacia IST408, the bceE::Tp/pDA17 and bceF::Tp/pDA17 mutants, and both complemented mutants. Bacteria were cultured in S medium in a 96-well microplate for 48 h and measured spectroscopically at a 590-nm wavelength. The data are means ± standard deviations from the results of at least three independent experiments. (C) Scanning confocal photomicrographs of surface-attached communities formed by B. cepacia IST408 wild type and the isogenic mutants bceE::Tp and bceF::Tp labeled with GFP. The biofilms were grown in flowthrough continuous culture reaction vessels for 48 h at 30°C in S medium. Shown in the right and lower frames are vertical sections through the biofilms. Bar, 20 μm.

Inactivation of the bceF gene increases the production of cyclic-di-GMP.

Microarray data showed the altered expression of genes BCAL1069, BCAL0430, and BCAM1670, which are putatively involved in cyclic-di-GMP signaling (Table 2). Genes BCAL0430 and BCAM1670, encoding putative cyclic-di-GMP diguanylate cyclases with a GGDEF domain, showed 1.7- to 2.0-fold increased expression in the bceF::Tp mutant. In contrast, gene BCAL1069, which encodes a putative cyclic-di-GMP phosphodiesterase, showed 1.5-fold decreased expression. As an overview, the genome of B. cenocepacia J2315 has at least 25 genes involved in cyclic-di-GMP production and turnover. Therefore, it is difficult to predict whether changes in the expression of genes encoding digualylate cyclases and phosphodiesterases will have an effect on the cyclic-di-GMP concentration. To assess whether BCAL1069, BCAL0430, and BCAM1670 gene products are relevant in the regulation of intracellular cyclic-di-GMP levels in B. cepacia, this secondary messenger was extracted from cells of the wild-type IST408 and bceE::Tp and bceF::Tp mutants at 12, 24, and 48 h of growth in S medium (Fig. 6). The intracellular level of cyclic-di-GMP in the wild-type IST408 and bceE::Tp mutant did not change over the 48-h test period, with the mutant showing a slightly higher concentration. In contrast, the bceF::Tp mutant showed at least a 4-fold increase of cyclic-di-GMP levels above the wild-type B. cepacia IST408 in the first 24 h, with the concentration dropping to levels similar to the bceE::Tp mutant but still 2-fold higher than in the IST408 strain (Fig. 6).
Fig 6
Fig 6 Intracellular cyclic-di-GMP contents in wild-type B. cepacia IST408 and the bceE::Tp and bceF::Tp mutants. Intracellular nucleotides were extracted at 12, 24, and 48 h of growth, and the cyclic-di-GMP content was measured by reverse-phase HPLC. The amount of cyclic-di-GMP is shown per milligram (dry weight) of cells. The data are means ± standard deviations from the results of at least three independent experiments.

The bceF gene plays a role in virulence.

Mutation in the bceF gene affected diverse phenotypes, such as motility, resistance to stress, and biofilm formation, among others. Due to the importance of these phenotypes in B. cepacia virulence, we determined whether the bceF::Tp mutant could also be attenuated in virulence by using Galleria mellonella as an acute infection model. This was accomplished by injecting approximately 2 × 106 CFU of each bacterial strain into larvae. The results indicated virulence attenuation by the bceF::Tp mutant, with 35% of the larvae being alive at 48 h postinfection, while in the presence of the bceE::Tp mutant and the wild-type IST408 almost all larvae were dead (Fig. 7). Complementation of the bceF::Tp mutant with pDA17 expressing the bceF gene restored virulence to the wild-type level. These data regarding virulence attenuation of the bceF::Tp mutant are consistent with the decreased expression of genes putatively involved in virulence as well as the observed phenotypic properties.
Fig 7
Fig 7 BceF influences the ability of B. cepacia IST408 to kill G. mellonella. Larvae were infected with approximately 2 × 106 cells of IST408/pDA17 (◆), bceE::Tp/pDA17 (○), bceF::Tp/pDA17 (□), and bceF::Tp/+pbceF (■). The control experiment without bacteria is also shown (▲). The data are means ± standard deviations from the results of at least three independent experiments.

DISCUSSION

In this work we performed global gene expression analysis and a series of in vivo experiments looking for phenotypes of a B. cepacia strain with an inactivated bceF gene encoding a BY-kinase primarily involved in cepacian exopolysaccharide biosynthesis. The results showed a remarkable effect on the number of genes differentially expressed between the wild-type and mutant strains. Considering that BceF activity is expected to be mainly at the protein level, its effect on gene expression regulation might be an indirect one. Nevertheless, these changes in gene expression have many consequences at the phenotype level, as observed for exopolysaccharide production, resistance to stress, motility, biofilm formation, and virulence. Another finding from this work is that the lack of BceF activity is not compensated by other BY-kinases predicted to be present in Burkholderia. Effectively, our search of several Bcc sequenced genomes for BceF homologues indicated that, in addition to BceF homologues, most of them encode another putative BY-kinase, described by Fazli and collaborators to be involved in the biosynthesis of a new polysaccharide (26). B. cenocepacia J2315 is an exception, having two extra BY-kinases besides BceF, namely, BCAM0207 and BCAM1331.
Consistent with the decreased expression of genes involved in DNA repair and response to stress, B. cepacia cells lacking the BceF protein were more susceptible to stress imposed by exposure to UV irradiation or heat shock. The role of tyrosine phosphorylation in the regulation of responses to stress in E. coli and B. subtilis has been reported. The B. subtilis mutant in the PtkA BY-kinase was slightly less resistant than the wild-type strain when exposed to gamma irradiation-induced DNA lesions (44). As the single-strand-binding protein SsbA from B. subtilis is a tyrosine phosphorylation target, those authors suggested the need for PtkA (and the phosphatase PtpZ) to coordinate a cycle of SsbA coming on and off the single-stranded DNA template during repair (44), which would explain the more sensitive phenotype to radiation stress. With regard to heat shock stress, the role of tyrosine phosphorylation/dephosphorylation in the control of RpoH and RseA activities has also been previously described (9). In that work, the authors demonstrated that RpoH was phosphorylated at amino acid position 260 and that this phosphorylation event attenuated RpoH activity by inhibiting its ability to initiate transcription as a sigma factor. Our expression data indicate that in the absence of BceF tyrosine kinase, expression of both the rpoH gene and some of its putative regulon members decreased. Although it cannot be excluded that there is a possible effect of tyrosine phosphorylation on RpoH activity, our data point toward a reduction in the expression of the rpoH gene as the main cause for the lower fitness of the mutant under stress conditions. Effectively, when extra copies of the rpoH gene were introduced into the bceF mutant, both UV and heat shock resistance increased to wild-type levels.
Another line of investigation was focused on the effect of the absence of BceF on motility, biofilm formation, cyclic-di-GMP synthesis, and virulence. These are complex phenotypes with different levels of regulation and are difficult to attribute to a single factor. In a recent work, Fazli and colleagues characterized a transcriptional regulator of the CRP/FNR superfamily (BCAM1349) from B. cenocepacia J2315 that is able to bind cyclic-di-GMP (45). This transcriptional regulator was shown to regulate the expression of genes required for the synthesis of cellulose and fimbriae, as it was involved in biofilm formation and virulence of B. cenocepacia in response to the level of cyclic-di-GMP. Also in Burkholderia pseudomallei, the presence of higher intracellular cyclic-di-GMP levels in a phosphodiesterase cdpA-null mutant was associated with an absence of flagella and swimming motility and increased biofilm formation (46). According to these previous observations, the lower motility displayed by the bceF::Tp mutant could be a consequence of the higher levels of cyclic-di-GMP in this mutant. With regard to biofilm formation, our results showed an opposite effect, since the bceF::Tp mutant strain had higher levels of cyclic-di-GMP but nevertheless showed less biofilm formation. Certainly the level of cyclic-di-GMP and the transcriptional control dependent on this secondary messenger are not the only factors for biofilm formation. It has been shown with E. coli K-12 that the EnvZ-OmpR two-component regulatory system also controls both fimbriae and biofilm formation (42). Both OmpR and fimbria-encoding genes showed decreased expression in the bceF mutant, and this could perhaps explain the inability of the mutant to form biofilms with a size comparable to the wild-type B. cepacia. In addition, posttranslational modifications are also involved in the control of biofilm formation, namely, phosphorylation of protein tyrosine residues. A B. subtilis strain harboring the PtkA tyrosine kinase with mutations affecting kinase activity was unable to develop the complex radial structures typical of a maturing wild-type biofilm (47). Nevertheless, the targets controlled by these BY-kinases with direct involvement in biofilm formation are unknown.
With regard to virulence, protein phosphorylation is often directly involved in this process, as it controls the expression of virulence genes and the synthesis of macromolecules from the bacterial cell wall and also interferes directly with host signaling (48). The B. cepacia bceF::Tp mutant was clearly less virulent than the wild-type strain in the acute infection model with G. mellonella used in this work and also in a mouse infection model (29). Several factors can contribute to this virulence attenuation in the absence of the BceF protein. One of them could be related to altered membrane permeability and cell envelope composition, as suggested by experiments involving differential expression of genes related to lipid metabolism and cell wall polymer biosynthesis. These changes may have a strong impact on the modulation of the host immune response. Another reason could be the different abilities to attach to host tissues due to differential expression of pili, fimbriae, flagella, or other proteins important in this process. For example, the chaperone GroEL from Salmonella enterica serovar Typhimurium and Clostridium difficile has been experimentally demonstrated to participate in adhesion to eukaryotic cells (49, 50). Therefore, the decreased expression of genes encoding heat shock proteins and other RpoH regulon members, together with the reduced ability of Burkholderia to withstand stress conditions, suggests that upon encountering a stressful environment during host infection, the cells may become less proficient for survival within the host. In addition, the BceF protein may indirectly interfere with host signaling by being involved in the activation and secretion of some effector protein for which, in its absence, cells would be less virulent.
Taken together, the bceF mutant seems to have complex pleiotropic phenotypes related to polysaccharide synthesis, metabolism, stress response, signaling, and biofilm formation, among others. This reflects the importance of protein phosphorylation, in particular the tyrosine kinase BceF from Burkholderia, in the regulation of key metabolic processes and virulence. The next aim is to identify cellular targets of this BY-kinase that could explain the observed differences at the gene expression and phenotypic levels.

ACKNOWLEDGMENTS

We acknowledge Sean May from University of Nottingham, United Kingdom, for his help with the Xspecies software.
This work was supported by FEDER and Fundação para a Ciência e a Tecnologia, Portugal (contracts PTDC/BIA-MIC/66977/2006 and PTDC/QUI-BIQ/118260/2010 to L.M.M.), a postdoctoral grant to A.S.F., and a doctoral grant to I.N.S. A.S.F. acknowledges a scholarship from Fundação Calouste Gulbenkian.

Supplemental Material

File (zam999104348so1.pdf)
File (zam999104348so2.pdf)
File (zam999104348so3.pdf)
File (zam999104348so4.pdf)
ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.

REFERENCES

1.
Grangeasse C, Terreux R, and Nessler S. 2010. Bacterial tyrosine-kinases: structure-function analysis and therapeutic potential. Biochim. Biophys. Acta 1804: 628–634.
2.
Lee DC and Jia Z. 2009. Emerging structural insights into bacterial tyrosine kinases. Trends Biochem. Sci. 34: 351–357.
3.
Bechet E, Guiral S, Torres S, Mijakovic I, Cozzone AJ, and Grangeasse C. 2009. Tyrosine-kinases in bacteria: from a matter of controversy to the status of key regulatory enzymes. Amino Acids 37: 499–507.
4.
Lacour S, Bechet E, Cozzone AJ, Mijakovic I, and Grangeasse C. 2008. Tyrosine phosphorylation of the UDP-glucose dehydrogenase of Escherichia coli is at the crossroads of colanic acid synthesis and polymyxin resistance. PLoS One 3: e3053. doi:https://doi.org/10.1371/journal.pone.0003053.
5.
Mijakovic I, Poncet S, Boel G, Maze A, Gillet S, Jamet E, Decottignies P, Grangeasse C, Doublet P, Le Marechal P, and Deutscher J. 2003. Transmembrane modulator-dependent bacterial tyrosine kinase activates UDP-glucose dehydrogenases. EMBO J. 22: 4709–4718.
6.
Minic Z, Marie C, Delorme C, Faurie JM, Mercier G, Ehrlich D, and Renault P. 2007. Control of EpsE, the phosphoglycosyltransferase initiating exopolysaccharide synthesis in Streptococcus thermophilus, by EpsD tyrosine kinase. J. Bacteriol. 189: 1351–1357.
7.
Lin MH, Hsu TL, Lin SY, Pan YJ, Jan JT, Wang JT, Khoo KH, and Wu SH. 2009. Phosphoproteomics of Klebsiella pneumoniae NTUH-K2044 reveals a tight link between tyrosine phosphorylation and virulence. Mol. Cell. Proteomics 8: 2613–2623.
8.
Soulat D, Grangeasse C, Vaganay E, Cozzone AJ, and Duclos B. 2007. UDP-acetyl-mannosamine dehydrogenase is an endogenous protein substrate of Staphylococcus aureus protein-tyrosine kinase activity. J. Mol. Microbiol. Biotechnol. 13: 45–54.
9.
Klein G, Dartigalongue C, and Raina S. 2003. Phosphorylation-mediated regulation of heat shock response in Escherichia coli. Mol. Microbiol. 48: 269–285.
10.
Kolot M, Gorovits R, Silberstein N, Fichtman B, and Yagil E. 2008. Phosphorylation of the integrase protein of coliphage HK022. Virology 375: 383–390.
11.
Mijakovic I, Petranovic D, Macek B, Cepo T, Mann M, Davies J, Jensen PR, and Vujaklija D. 2006. Bacterial single-stranded DNA-binding proteins are phosphorylated on tyrosine. Nucleic Acids Res. 34: 1588–1596.
12.
Macek B, Gnad F, Soufi B, Kumar C, Olsen JV, Mijakovic I, and Mann M. 2008. Phosphoproteome analysis of E. coli reveals evolutionary conservation of bacterial Ser/Thr/Tyr phosphorylation. Mol. Cell. Proteomics 7: 299–307.
13.
Macek B, Mijakovic I, Olsen JV, Gnad F, Kumar C, Jensen PR, and Mann M. 2007. The serine/threonine/tyrosine phosphoproteome of the model bacterium Bacillus subtilis. Mol. Cell. Proteomics 6: 697–707.
14.
Eymann C, Becher D, Bernhardt J, Gronau K, Klutzny A, and Hecker M. 2007. Dynamics of protein phosphorylation on Ser/Thr/Tyr in Bacillus subtilis. Proteomics 7: 3509–3526.
15.
Misra SK, Milohanic E, Aké F, Mijakovic I, Deutscher J, Monnet V, and Henry C. 2011. Analysis of the serine/threonine/tyrosine phosphoproteome of the pathogenic bacterium Listeria monocytogenes reveals phosphorylated proteins related to virulence. Proteomics 11: 4155–4165.
16.
Sun X, Ge F, Xiao CL, Yin XF, Ge R, Zhang LH, and He QY. 2010. Phosphoproteomic analysis reveals the multiple roles of phosphorylation in pathogenic bacterium Streptococcus pneumoniae. J. Proteome Res. 9: 275–282.
17.
Ravichandran A, Sugiyama N, Tomita M, Swarup S, and Ishihama Y. 2009. Ser/Thr/Tyr phosphoproteome analysis of pathogenic and non-pathogenic Pseudomonas species. Proteomics 9: 2764–2775.
18.
Mijakovic I and Macek B. 2012. Impact of phosphoproteomics on studies of bacterial physiology. FEMS Microbiol. Rev. 36: 877–892.
19.
Ge R and Shan W. 2011. Bacterial phosphoproteomic analysis reveals the correlation between protein phosphorylation and bacterial pathogenicity. Genomics Proteomics Bioinformatics 9: 119–127.
20.
Jers C, Pedersen MM, Paspaliari DK, Schütz W, Johnsson C, Soufi B, Macek B, Jensen PR, and Mijakovic I. 2010. Bacillus subtilis BY-kinase PtkA controls enzyme activity and localization of its protein substrates. Mol. Microbiol. 77: 287–299.
21.
Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, and Levison H. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104: 206–210.
22.
Richau JA, Leitão JH, Correia M, Lito L, Salgado MJ, Barreto C, Cescutti P, and Sá-Correia I. 2000. Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a Portuguese cystic fibrosis center. J. Clin. Microbiol. 38: 1651–1655.
23.
Zlosnik JE, Hird TJ, Fraenkel MC, Moreira LM, Henry DA, and Speert DP. 2008. Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex. J. Clin. Microbiol. 46: 1470–1473.
24.
Ferreira AS, Leitão JH, Silva IN, Pinheiro PF, Sousa SA, Ramos CG, and Moreira LM. 2010. Distribution of cepacian biosynthesis genes among environmental and clinical Burkholderia strains and role of cepacian exopolysaccharide in resistance to stress conditions. Appl. Environ. Microbiol. 76: 441–450.
25.
Ferreira A, Silva I, Oliveira V, Cunha R, and Moreira L. 2011. Insights into the role of extracellular polysaccharides in Burkholderia adaptation to different environments. Front. Cell. Infect. Microbiol. 1: 00016. doi:https://doi.org/10.3389/fcimb.2011.00016.
26.
Fazli M, McCarthy Y, Givskov M, Ryan RP, and Tolker-Nielsen T. 2012. The exopolysaccharide gene cluster Bcam1330-Bcam1341 is involved in Burkholderia cenocepacia biofilm formation, and its expression is regulated by c-di-GMP and Bcam1349. MicrobiologyOpen doi:https://doi.org/10.1002/mbo3.61.
27.
Moreira LM, Videira PA, Sousa SA, Leitão JH, Cunha MV, and Sá-Correia I. 2003. Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide. Biochem. Biophys. Res. Commun. 312: 323–333.
28.
Ferreira AS, Leitão JH, Sousa SA, Cosme AM, Sá-Correia I, and Moreira LM. 2007. Functional analysis of Burkholderia cepacia genes bceD and bceF, encoding a phosphotyrosine phosphatase and a tyrosine autokinase, respectively: role in exopolysaccharide biosynthesis and biofilm formation. Appl. Environ. Microbiol. 73: 524–534.
29.
Sousa SA, Ulrich M, Bragonzi A, Burke M, Worlitzsch D, Leitão JH, Meisner C, Eberl L, Sá-Correia I, and Döring G. 2007. Virulence of Burkholderia cepacia complex strains in gp91phox-/- mice. Cell. Microbiol. 9: 2817–2825.
30.
Sambrook J and Russell DW. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
31.
Silva IN, Ferreira AS, Becker JD, Zlosnik JEA, Speert DP, He J, Mil-Homens D, and Moreira LM. 2011. Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence. Microbiology 157: 3124–3137.
32.
Hammond JP, Broadley MR, Craigon DJ, Higgins J, Emmerson ZF, Townsend HJ, White PJ, and May ST. 2005. Using genomic DNA-based probe-selection to improve the sensitivity of high-density oligonucleotide arrays when applied to heterologous species. Plant Methods 1: 10. doi:https://doi.org/10.1186/1746-4811-1-10.
33.
Li C and Wong WH. 2001. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol. 2: RESEARCH0032. doi:https://doi.org/10.1186/gb-2001-2-8-research0032.
34.
Li C and Wong WH. 2001. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. U. S. A. 98: 31–36.
35.
Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29: e45. doi:https://doi.org/10.1093/nar/29.9.e45.
36.
Ryan RP, Lucey J, O'Donovan K, McCarthy Y, Yang L, Tolker-Nielsen T, and Dow JM. 2009. HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa. Environ. Microbiol. 11: 1126–1136.
37.
Cunha MV, Sousa SA, Leitão JH, Moreira LM, Videira PA, and Sá-Correia I. 2004. Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J. Clin. Microbiol. 42: 3052–3058.
38.
Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersbøll BK, and Molin S. 2000. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146: 2395–2407.
39.
Seed KD and Dennis JJ. 2008. Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia complex. Infect. Immun. 76: 1267–1275.
40.
Zhou P, Hu R, Chandan V, Kuolee R, Liu X, Chen W, Liu B, Altman E, and Li J. 2012. Simultaneous analysis of cardiolipin and lipid A from Helicobacter pylori by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Mol. Biosyst. 8: 720–725.
41.
Gao H, Zhang Y, Han Y, Yang L, Liu X, Guo Z, Tan Y, Huang X, Zhou D, and Yang R. 2011. Phenotypic and transcriptional analysis of the osmotic regulator OmpR in Yersinia pestis. BMC Microbiol. 11: 39. doi:https://doi.org/10.1186/1471-2180-11-39.
42.
Vidal O, Longin R, Prigent-Combaret C, Dorel C, Hooreman M, and Lejeune P. 1998. Isolation of an Escherichia coli K-12 mutant strain able to form biofilms on inert surfaces: involvement of a new ompR allele that increases curli expression. J. Bacteriol. 180: 2442–2449.
43.
Guisbert E, Yura T, Rhodius VA, and Gross CA. 2008. Convergence of molecular, modeling, and systems approaches for an understanding of the Escherichia coli heat shock response. Microbiol. Mol. Biol. Rev. 72: 545–554.
44.
Petranovic D, Michelsen O, Zahradka K, Silva C, Petranovic M, Jensen PR, and Mijakovic I. 2007. Bacillus subtilis strain deficient for the protein-tyrosine kinase PtkA exhibits impaired DNA replication. Mol. Microbiol. 63: 1797–1805.
45.
Fazli M, O'Connell A, Nilsson M, Niehaus K, Dow JM, Givskov M, Ryan RP, and Tolker-Nielsen T. 2011. The CRP/FNR family protein Bcam1349 is a c-di-GMP effector that regulates biofilm formation in the respiratory pathogen Burkholderia cenocepacia. Mol. Microbiol. 82: 327–341.
46.
Lee HS, Gu F, Ching SM, Lam Y, and Chua KL. 2010. CdpA is a Burkholderia pseudomallei cyclic di-GMP phosphodiesterase involved in autoaggregation, flagellum synthesis, motility, biofilm formation, cell invasion, and cytotoxicity. Infect. Immun. 78: 1832–1840.
47.
Kiley TB and Stanley-Wall NR. 2010. Post-translational control of Bacillus subtilis biofilm formation mediated by tyrosine phosphorylation. Mol. Microbiol. 78: 947–963.
48.
Jers C, Soufi B, Grangeasse C, Deutscher J, and Mijakovic I. 2008. Phosphoproteomics in bacteria: towards a systemic understanding of bacterial phosphorylation networks. Expert Rev. Proteomics 5: 619–627.
49.
Ensgraber M and Loos M. 1992. A 66-kilodalton heat shock protein of Salmonella typhimurium is responsible for binding of the bacterium to intestinal mucus. Infect. Immun. 60: 3072–3078.
50.
Hennequin C, Porcheray F, Waligora-Dupriet A, Collignon A, Barc M, Bourlioux P, and Karjalainen T. 2001. GroEL (Hsp60) of Clostridium difficile is involved in cell adherence. Microbiology 147: 87–96.
51.
Bullock WC, Fernandz JM, and Short JM. 1987. XL1-Blue: a high efficiency plasmid transforming recA Escherichia coli strain with beta-galactosidase selection. Biotechniques 5: 376–379.
52.
Figurski DH and Helinski DR. 1979. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc. Natl. Acad. Sci. U. S. A. 76: 1648–1652.
53.
Sokol PA, Darling P, Woods DE, Mahenthiralingam E, and Kooi C. 1999. Role of ornibactin biosynthesis in the virulence of Burkholderia cepacia: characterization of pvdA, the gene encoding L-ornithine N(5)-oxygenase. Infect. Immun. 67: 4443–4455.
54.
Keith KE and Valvano MA. 2007. Characterization of SodC, a periplasmic superoxide dismutase from Burkholderia cenocepacia. Infect. Immun. 75: 2451–2460.
55.
Vergunst AC, Meijer AH, Renshaw SA, and O'Callaghan D. 2010. Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection. Infect. Immun. 78: 1495–1508.

Information & Contributors

Information

Published In

cover image Applied and Environmental Microbiology
Applied and Environmental Microbiology
Volume 79Number 91 May 2013
Pages: 3009 - 3020
PubMed: 23435894

History

Received: 28 January 2013
Accepted: 20 February 2013
Published online: 10 April 2013

Permissions

Request permissions for this article.

Contributors

Authors

Ana S. Ferreira
Institute for Biotechnology and Bioengineering, Centre for Biological and Chemical Engineering, Instituto Superior Técnico, Lisbon, Portugal
Inês N. Silva
Institute for Biotechnology and Bioengineering, Centre for Biological and Chemical Engineering, Instituto Superior Técnico, Lisbon, Portugal
Vítor H. Oliveira
Institute for Biotechnology and Bioengineering, Centre for Biological and Chemical Engineering, Instituto Superior Técnico, Lisbon, Portugal
Jörg D. Becker
Instituto Gulbenkian de Ciência, Oeiras, Portugal
Michael Givskov
Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark, and Singapore Centre on Environmental Life Sciences Engineering, Nanyang Technological University, Singapore
Robert P. Ryan
Division of Molecular Microbiology, College of Life Sciences, University of Dundee, Dundee, United Kingdom
Fábio Fernandes
Centro de Química Física Molecular and Institute of Nanosciences and Nanotechnologies, Instituto Superior Técnico, Lisbon, Portugal
Leonilde M. Moreira
Department of Bioengineering, Instituto Superior Técnico, Lisbon, Portugal
Institute for Biotechnology and Bioengineering, Centre for Biological and Chemical Engineering, Instituto Superior Técnico, Lisbon, Portugal

Notes

Address correspondence to Leonilde M. Moreira, [email protected].

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures

Tables

Media

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy